Division of Medicinal Chemistry and Pharmacognosy Guest Seminar Series

Start date
End date
Location
202 Parks Hall
Event Content

Title: Discovery of a Ketohexokinase (KHK) inhibitor for the treatment of NAFLD/NASH: Fragment-to-clinic

Speaker: Dr. David Price, Vice President, Discovery Network Group, Medicine Design, Pfizer, Inc.